Literature DB >> 16773415

Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis.

Sashikala Kopanati1, Michel Baum, Albert Quan.   

Abstract

Glomerular protein permeability rises in nephrotic syndrome and may result from the effect of an unidentified "circulating factor." The effect of this "circulating factor" on the permeability of other body membranes is unknown. In this study we examine the peritoneal membrane protein permeability in patients with nephrotic syndrome on chronic-cycler peritoneal dialysis. We conducted a retrospective study of peritoneal protein losses in the dialysate effluent of 60 pediatric peritoneal dialysis patients (ages 5.1-22 years) over a 6-year period (January 1997-December 2002). Nineteen patients had steroid-resistant nephrotic syndrome (SRNS), while 41 had other non-nephrotic etiologies of renal failure. Total and normalized peritoneal protein losses are higher in SRNS than in non-nephrotic patients (12,603+/-5,403 mg/day vs 4,475+/-469 mg/day, P<0.05; 297.8+/-79.3 mg/kg per day vs 156.8+/-16.0 mg/kg per day, P<0.05; 9,614.6+/-3,253.4 mg/m(2) per day vs 4,168.3+/-367.3 mg/m(2) per day, P<0.05). The ratio of total protein in dialysate to plasma, a measure of peritoneal membrane protein permeability, was higher in SRNS patients (3.50+/-1.00% vs 0.68+/-0.06%, P<0.001). Serum albumin concentration was lower in SRNS patients (3.09+/-0.13 mg/dl vs 3.52+/-0.07 mg/dl, P<0.01). There were no differences between the two groups with regard to duration of peritoneal dialysis, dialysis prescription, numbers of peritonitis episodes, catheter replacements, or hospitalizations. In summary, these results demonstrate that peritoneal protein losses in patients with SRNS are twice as great as in those without nephrotic syndrome. These results are consistent with the systemic effect of a "circulating factor" in SRNS and underscore the importance of adequate protein intake in patients on peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773415     DOI: 10.1007/s00467-006-0012-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  24 in total

1.  Peritoneal transport properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dialysis. Mid-European Pediatric Peritoneal Dialysis Study Group.

Authors:  F Schaefer; G Klaus; O Mehls
Journal:  J Am Soc Nephrol       Date:  1999-08       Impact factor: 10.121

2.  The assessment of body water and fatness from infancy to adulthood.

Authors:  E D Mellits; D B Cheek
Journal:  Monogr Soc Res Child Dev       Date:  1970-10

3.  Clinical and histological sequence of recurrent focal segmental glomerulosclerosis.

Authors:  J M Morales; A Andrés; C Prieto; M A Martínez; M Praga; L M Ruilope; V Gutiérrez Millet; J L Rodicio
Journal:  Nephron       Date:  1988       Impact factor: 2.847

4.  Recurrent focal sclerosis after renal transplantation.

Authors:  E J Lewis
Journal:  Kidney Int       Date:  1982-09       Impact factor: 10.612

5.  Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children.

Authors: 
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

6.  Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome.

Authors:  J Dantal; Y Godfrin; R Koll; S Perretto; J Naulet; J F Bouhours; J P Soulillou
Journal:  J Am Soc Nephrol       Date:  1998-09       Impact factor: 10.121

7.  Protein losses during peritoneal dialysis.

Authors:  M J Blumenkrantz; G M Gahl; J D Kopple; A V Kamdar; M R Jones; M Kessel; J W Coburn
Journal:  Kidney Int       Date:  1981-04       Impact factor: 10.612

8.  Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys.

Authors:  S M Feld; P Figueroa; V Savin; C C Nast; R Sharma; M Sharma; R Hirschberg; S G Adler
Journal:  Am J Kidney Dis       Date:  1998-08       Impact factor: 8.860

9.  Focal glomerulosclerosis and renal transplantation.

Authors:  M H Malekzadeh; E T Heuser; R B Ettenger; A J Pennisi; C H Uittenbogaart; B L Warshaw; R N Fine
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

10.  The long-term prognosis of patients with focal segmental glomerulosclerosis.

Authors:  J S Cameron; D R Turner; C S Ogg; C Chantler; D G Williams
Journal:  Clin Nephrol       Date:  1978-12       Impact factor: 0.975

View more
  2 in total

1.  The plasma permeability factor in nephrotic syndrome: indirect evidence in pediatric peritoneal dialysis.

Authors:  Marta Azocar; Lily Quiroz; Angela Delucchi; Hector Dinamarca; Marcos Emilfork; Francisco Cano
Journal:  Perit Dial Int       Date:  2012-04-02       Impact factor: 1.756

2.  Peritoneal dialysis outcomes in patients with nephrotic syndrome: a propensity score-matched cohort study.

Authors:  Si-Jia Zhou; Ya-Kun Cong; Qing-Feng Han; Wen Tang; Tao Wang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.